Introduction
============

Pharmacovigilance is the science and activity relating to the collection, detection, assessment, monitoring, and prevention of adverse effects with pharmaceutical products \[[@r1]\]. The word \"pharmacovigilance\" is derived from pharmakon (drug in Greek) and vigilare (keep an eye on/ monitor in Latin). Pharmacovigilance basically targets safety of medicines. Ultimately, pharmacovigilance is concerned with identifying the hazards associated with pharmaceutical products and with minimizing the risk of any harm that the patients can face \[[@r1],[@r2]\]. In modern data-intensive era, pharmacovigilance information systems, operating like disease surveillance systems, can enhance the data collection, detection, assessment, monitoring and prevention of adverse effects.Effective and safe pharmacological treatment process requires a team work of the patient and healthcare professionals. Pharmaceutical care includes considering these risks on a patient-oriented basis by ''identifying and solving (or avoiding)'' drug therapy problems. Although the prescription is written by medical doctors in most countries, pharmacists and nurses have a crucial role in follow-up, since they can monitor and determine drug related problems; thus maintain safe use of medicines \[[@r3],[@r4]\].Traditional pharmacy practice typically focuses on filling orders (prescription/ OTC), received from medical practitioners. In this model, pharmacists provide a service focused on the dispensing of medicine, rather than the provision of individualized care to the patient \[[@r5],[@r6]\]. However, evidence suggests that patients often receive inadequate care using this traditional model \[[@r7]-[@r9]\]. On the other hand, pharmaceutical care is improved when pharmacists are actively involved in the treatment procedure by fostering the pharmacist--patient relationship and enhancing the value of the clinical outcome of the treatment \[[@r10],[@r11]\]. The role of pharmacists in pharmacovigilance systems is amplified under Affordable Care Act or the current health care reform, because people who otherwise had no insurance, now qualify for insurance; and this could increase the demand for pharmacy services. More pharmacists will be required in delivering health education, including education on drug-drug interaction \[[@r12]\]. Also, in developing countries, pharmacists have a distinct role in in the health care system since many patients in prefer going to pharmacies for primary care. In such countries, pharmacists are more involved in the treatment process as well as the patient education \[[@r13]\]. Pharmacovigilance information systems, managed by pharmacists, can identify adverse drug reactions in developing countries where quality control of medicines is questionable.The study by Akici et al (2007) showed that patients had insufficient knowledge about their prescribed drugs, although they had been using them for a while \[[@r14]\]. Another problem is ignorant use of herbs and herbal medicine \[[@r15]\]. Since many herbal products contain active ingredients that can interact with prescription medicines, WHO prepared a guideline on monitoring of herbal medicine in the pharmacovigilance systems \[[@r16]\]. In most countries, pharmacists go through an extensive education on medicinal plants which are used in traditional folk medicine, as well as the natural and synthetic medicines. Therefore, pharmacists already have the knowledge to detect safety signals of drugs of any origin \[[@r17]\].

Signal detection is important to identify the drug related adverse effects. However, the number of reports sent to national pharmacovigilance centers is also important as well as the quality of reports. The quality of reports is definitely superior when they are filled by health professionals who have pharmacology knowledge, i.e. pharmacists, doctors, nurses, physician assistants, dentists etc. It will be even better if it can be documented and retrieved from pharmacy information systems.

According to the 2012 FIP Pharmacist Workforce Report, global sample reveals that, on average, 55% of pharmacists were found to work in community pharmacy environments, 18% in hospitals, 10% in industry, 5% in research and academia and 5% in regulation \[[@r18]\]. Roughly, 73% of pharmacists work in hospital or pharmacy settings, where they can face events based on adverse drug reactions or other drug related problems. Their involvement in pharmacovigilance systems is crucial.

The changing role of the pharmacist from traditional 'drug dispenser' concept towards 'pharmaceutical care provider' expanded the role of pharmacists \[[@r13]\]. Pharmacists' role has become essential for the management of chronic diseases in patient-centered medical facilities where pharmacists are constituents of primary care \[[@r19]\]. Furthermore, the development of electronic information systems has been a milestone in identifying and intervening drug related problems such as dosage, adverse reactions, interactions, compliance or ineffectiveness \[[@r20]\]. Such decision support systems in electronic medical records can capture drug-drug interactions or identify other issues (e.g. contraindications) with prescriptions before they are filled. Thus, they improve safety. Such systems have also been shown to improve productivity of the providers as well as saving time \[[@r21]\]. Moreover, these databases provide a valuable source for cost-effectiveness/ outcome analysis.

Because of the above mentioned reasons, pharmacists should be used more effectively in the system. They need to be directly involved in adverse drug reaction reporting using information systems to improve their performance. To reach this goal, regulatory bodies should make legislations to encourage pharmacists to be actively involved in the system. Besides their active participation, their assigned role should have a broader spectrum to obtain the maximum benefit based on their expertise. A sample organization scheme suggested for involving pharmacist in pharmacovigilance systems is given in [Figure 1](#f1){ref-type="fig"}. This simple organizational scheme can be adapted in many countries effectively. The performance of this system can be enhanced by the use of information and communication technologies.Fig. 1A sample organizational scheme suggested for involving pharmacist role in the pharmacovigilance system. This simple organization scheme can be adapted in many countries effectively.

Since rational use of medicines requires that the patients receive "medicines appropriate to their clinical needs, in doses that meet their own individual requirements, for an adequate period of time, at the lowest cost to them and their community"; active/ more effective involvement of pharmacists in pharmacovigilance systems will improve the rational use of medicines.

Conclusion
==========

Pharmacovigilance basically targets safety of medicine. Pharmacists play crucial roles in health systems in maintaining the rational and safe use of medicines since they are drug experts who are specifically trained in this field. Effective use of pharmacists' workforce will improve the outcome of the pharmacotherapy as well as decrease global health costs.
